首頁
倫理決策輔助
哲學/宗教
1
1
基於功利主義與義務論框架，為商業倫理困境提供多維度分析，輔助管理者做出符合道德規範的決策。
提示內容
複製
複製
Act as a senior corporate ethics consultant to evaluate the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but insufficiently disclosed side effects with long-term use. Continuing sales maintains stock price and employment but violates patient知情权 (right to know). Please analyze the moral conflict in this context by combining the utilitarian principle of maximizing happiness with the deontological requirement of respecting individual autonomy. Provide a comprehensive recommendation that balances legal compliance, corporate social responsibility, and long-term reputation management, ensuring the logic is rigorous and actionable.
複製
請扮演資深企業倫理顧問，針對以下具體商業場景進行道德評估：一家製藥公司發現其暢銷藥物在長期服用後存在輕微但未被充分披露的副作用，繼續銷售將維持公司股價和員工就業，但隱瞞信息違背患者知情權。請結合功利主義關於最大幸福的原則與義務論中尊重個體自主性的要求，分析該情境下的道德衝突，並給出一個兼顧法律合規、企業社會責任及長期聲譽管理的綜合建議方案，確保邏輯嚴密且具備可操作性。
複製
評論 (0)
0/300
推薦
倫理決策輔助
Act as a corporate ethics consultant to provide decision-making advice for the following specific business scenario: A pharmaceutical company discovers that its marketed drug causes severe side effects in a very small number of long-term users, but a recall would bankrupt the company and affect thousands of patients relying on it. Please evaluate the moral weight of three paths—recall, concealment, or limited disclosure—by combining utilitarian consequence analysis with deontological respect for human dignity, and provide a specific action framework that balances social responsibility and corporate survival, avoiding rigid instructional language and narrating the reasoning process naturally.
倫理決策輔助
Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that its established basic drug has potential serious side effects for a very small number of individuals with specific genetic profiles after long-term use, but the cost of recall would lead to company bankruptcy and affect medication accessibility for millions of ordinary patients. Please evaluate the ethical weights of both recall and non-recall options by combining the utilitarian principle of the greatest happiness for the greatest number with the deontological perspective of moral responsibility for harm to individuals, and provide a balanced recommendation that balances business sustainability with moral legitimacy, focusing on how to distribute risks and responsibilities among stakeholders.
倫理決策輔助
Act as a senior corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its marketed drug causes mild but reversible liver damage in long-term users, affecting only 0.5% of patients, with no alternative treatments available. The company must decide whether to immediately recall and suspend sales, which would cause stock price drops and shareholder lawsuits, but might save some patients' health. Please evaluate the moral weight of both recall and non-recall options using both utilitarian (maximizing overall well-being) and deontological (respecting patient autonomy and non-maleficence) ethical frameworks, and provide a final action recommendation that balances legal compliance, corporate social responsibility, and patient interests, ensuring rigorous logic and adherence to business ethics standards.
倫理決策輔助
Act as a senior corporate ethics consultant to analyze the moral risk of a specific business scenario I provide, which involves resource allocation or conflict of interest. Apply frameworks of utilitarianism and Kantian deontology to identify key stakeholders, assess potential social impact and compliance risks, and offer a balanced recommendation that considers both commercial benefits and social responsibility. Avoid abstract preaching; focus on practical ethical trade-offs in execution, ensuring the output is actionable and aligns with modern corporate governance standards.
倫理決策輔助
Act as a senior corporate ethics consultant and conduct a deep moral deduction for the following specific business scenario: A pharmaceutical company discovers that its flagship drug has mild but irreversible neurological side effects with long-term use. This drug remains the only effective treatment for a rare severe disease, and the company faces immense financial pressure to maintain its stock price to complete a merger. Please combine the utilitarian principle of the greatest happiness for the greatest number with the deontological principles of respecting patient autonomy and non-maleficence to analyze the ethical weights of continuing sales, voluntary recall, or reducing prices while disclosing information. Avoid simple binary judgments; instead, construct a comprehensive evaluation model including stakeholder impact, long-term reputational risk, and social trust costs, ultimately providing a balanced recommendation that balances business sustainability with moral responsibility.
倫理決策輔助
Please conduct an ethical analysis for the following specific business scenario: A pharmaceutical company discovers that its existing basic drug has minor but non-fatal side effects, and fixing it requires huge costs that could lead to price hikes. Please evaluate whether to proactively recall and disclose information by combining the impact on stakeholders from utilitarianism with the responsibility of honest disclosure from deontology, and finally provide an action recommendation that balances business survival and moral responsibility.
